Publication
Analysis of prognostic factors in advanced pancreatic cancer (APDAC) patients (pts) undergoing to first-line nab-paclitaxel (Nab-P) and gemcitabine (G) treatment.
Guido Giordano, Vanja Vaccaro, Eleonora Lucchini, Paola Bertocchi, Francesca Bergamo, Gianna Musettini, Matteo Santoni, Giovanni Lo Re, Elisa Giommoni, Marco Russano, Serena Campidoglio, Daniele Santini, Enrico Vasile, Stefano Cascinu, Vittorina Zagonel, Alberto Zaniboni, Davide Melisi, Michele Milella, Antonio Febbraro
Journal of Clinical Oncology, January 2015, American Society of Clinical Oncology (ASCO)
DOI: 10.1200/jco.2015.33.3_suppl.412